IE904161A1 - Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses - Google Patents

Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses

Info

Publication number
IE904161A1
IE904161A1 IE416190A IE416190A IE904161A1 IE 904161 A1 IE904161 A1 IE 904161A1 IE 416190 A IE416190 A IE 416190A IE 416190 A IE416190 A IE 416190A IE 904161 A1 IE904161 A1 IE 904161A1
Authority
IE
Ireland
Prior art keywords
hiv
recombinant
particles
nonreplicating
cell
Prior art date
Application number
IE416190A
Other languages
English (en)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of IE904161A1 publication Critical patent/IE904161A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IE416190A 1989-11-20 1990-11-19 Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses IE904161A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20
US61575690A 1990-11-19 1990-11-19

Publications (1)

Publication Number Publication Date
IE904161A1 true IE904161A1 (en) 1991-05-22

Family

ID=27031958

Family Applications (1)

Application Number Title Priority Date Filing Date
IE416190A IE904161A1 (en) 1989-11-20 1990-11-19 Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses

Country Status (5)

Country Link
CN (1) CN1054613A (pt)
IE (1) IE904161A1 (pt)
IL (1) IL96404A0 (pt)
MY (1) MY104530A (pt)
PT (1) PT95939A (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002694A1 (en) 1997-07-09 1999-01-21 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
CA2441287C (en) 2001-03-22 2014-06-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
CN104450631A (zh) * 2014-11-11 2015-03-25 中国人民解放军第四军医大学 肠道病毒ev71型vp1基因病毒样颗粒及其制备方法和应用

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002694A1 (en) 1997-07-09 1999-01-21 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
EP1002091A1 (en) * 1997-07-09 2000-05-24 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
EP1002091A4 (en) * 1997-07-09 2004-10-13 Univ Queensland NUCLEIC ACID SEQUENCE AND METHOD FOR SELECTIVE EXPRESSION OF A PROTEIN IN A TARGET CELL OR TISSUE

Also Published As

Publication number Publication date
PT95939A (pt) 1991-09-13
MY104530A (en) 1994-04-30
CN1054613A (zh) 1991-09-18
IL96404A0 (en) 1991-08-16

Similar Documents

Publication Publication Date Title
AU636944B2 (en) Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
JP3967374B2 (ja) 同調的インビボ遺伝子発現
JP6165612B2 (ja) コンセンサス／先祖免疫原
Stott et al. Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
Griffiths et al. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag: V3 fusion
Giavedoni et al. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
Rovinski et al. Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine
Luo et al. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells
Ahmad et al. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus
GB2181435A (en) Vaccines and immunoassays for acquired immune deficiency syndrome
Winter et al. Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice
IE921875A1 (en) Vaccine and treatment method for human immunodeficiency¹virus
JP2000506727A (ja) 組換え生ネコ免疫不全ウイルスおよびプロウイルスｄｎａワクチン
WARNER et al. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells
CA2077753C (en) Purified gp120 composition retaining natural conformation
HAYNES et al. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines
VAN EENDENBURG et al. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses
IE904161A1 (en) Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses
Mills et al. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
Schlienger et al. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge
Notka et al. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model
MONTEFIORI et al. Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection
WO1999019501A1 (en) Non-integrating dna vector of retroviral origin having high-protein expression, and secreted immunogenic antigens
Steimer et al. HIV-1 neutralization directed to epitopes other than linear V3 determinants
EP0276591B1 (fr) Vaccin constitué par un vecteur viral et ADN recombinant codant notamment pour la protéine p25 du virus agent causal du S.I.D.A.